test

Marsida Saraci

@Alphabet Inc.

Latest period2024 - Q3ReportedManaged Assets$1.842BTotal holdings42
Assets growth rate-6.69%Assets growth rate (2-Q avg)-14.07%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Alphabet Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.

Assets under management

The assets under management (AUM) of Alphabet Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.842B in assets, with a quarterly growth rate of -6.69% and a 2-quarter average growth rate of -14.07%. The portfolio is managed by Marsida Saraci, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PRMEPrime Medicine Inc
Recent Activity
3.17%
$58.292M
15.062M shares@ $3.87 avg price
SNOWSnowflake Inc
Recent Activity
Decreased -78.61%
0.72%
$13.158M
114,554 shares@ $114.86 avg price
SANASana Biotechnology Inc
Recent Activity
0.64%
$11.7M
2.812M shares@ $4.16 avg price
RLAYRelay Therapeutics Inc
Recent Activity
0.61%
$11.107M
1.569M shares@ $7.08 avg price
VERAVera Therapeutics Inc
Recent Activity
0.58%
$10.664M
241,264 shares@ $44.21 avg price
OSCROscar Health Inc
Recent Activity
0.56%
$10.223M
481,988 shares@ $21.21 avg price
LYELLyell Immunopharma Inc
Recent Activity
0.44%
$8.094M
5.865M shares@ $1.39 avg price
BEAMBeam Therapeutics Inc
Recent Activity
0.43%
$7.879M
321,604 shares@ $24.5 avg price
GLUEMonte Rosa Therapeutics Inc
Recent Activity
0.43%
$7.759M
1.464M shares@ $5.31 avg price
DNTHDianthus Therapeutics Inc
Recent Activity
0.32%
$5.714M
208,697 shares@ $27.39 avg price